Patient Guide: Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 113 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02951052
Status: ACTIVE_NOT_RECRUITING
Condition: Infection, Human Immunodeficiency Virus, HIV Infections
Phase: PHASE3

Find a Study Location Near You

This study is available at 113 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Phoenix, Arizona
  • Bakersfield, California
  • • And 110 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily